A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor. (Q51977253)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Makoto Mizuno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hidekazu Sotoyama

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Eri Narita

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hiroki Kawamura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hisaaki Namba

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Yingjun Zheng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Takeyoshi Eda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hiroyuki Nawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

10116-10127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

Histamine and prostaglandins in schizophrenia: revisited

7 January 2020

cites work

1 reference

12 December 2020

Cocaine upregulates the dopamine transporter in fetal rhesus monkey brain

1 reference

12 December 2020

What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies

1 reference

12 December 2020

Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture

1 reference

12 December 2020

Cyclooxygenases: structural, cellular, and molecular biology

1 reference

12 December 2020

Prostaglandin EP3 receptor protein in serotonin and catecholamine cell groups: a double immunofluorescence study in the rat brain

1 reference

12 December 2020

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

12 December 2020

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

1 reference

12 December 2020

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

12 December 2020

Evidence for the involvement of cyclooxygenase activity in the development of cocaine sensitization

1 reference

12 December 2020

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

1 reference

12 December 2020

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) regulates survival of midbrain dopaminergic neurons

1 reference

12 December 2020

Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death

1 reference

12 December 2020

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

1 reference

12 December 2020

Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients

1 reference

12 December 2020

Cyclooxygenase inhibitor modulation of dopamine-related behaviours

1 reference

12 December 2020

Differentiation status-dependent regulation of cyclooxygenase-2 expression and prostaglandin E2 production by epidermal growth factor via mitogen-activated protein kinase in articular chondrocytes

1 reference

12 December 2020

Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development

1 reference

12 December 2020

Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation

1 reference

12 December 2020

Differential involvement of dopamine in the anterior and posterior parts of the dorsal striatum in latent inhibition.

1 reference

12 December 2020

A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients

1 reference

12 December 2020

Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal

1 reference

12 December 2020

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

1 reference

12 December 2020

The role of the dorsal hippocampus in the acquisition and retrieval of context memory representations.

1 reference

12 December 2020

Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta

1 reference

12 December 2020

Association of EGF polymorphism with schizophrenia in Finnish men.

1 reference

12 December 2020

Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells

1 reference

12 December 2020

Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathways

1 reference

12 December 2020

Prostaglandin D2 mediates neuronal protection via the DP1 receptor

1 reference

12 December 2020

Post-training intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired spatial memory retention in rats

1 reference

12 December 2020

Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons

1 reference

12 December 2020

Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patients

1 reference

12 December 2020

Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strains.

1 reference

12 December 2020

COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date

1 reference

12 December 2020

Prostaglandin E receptor EP1 controls impulsive behavior under stress.

1 reference

12 December 2020

Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor.

1 reference

12 December 2020

Striatal dopaminergic responses observed in latent inhibition are dependent on the hippocampal ventral subicular region

1 reference

12 December 2020

Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells

1 reference

12 December 2020

Coxibs and Alzheimer's disease: should they stay or should they go?

1 reference

12 December 2020

Contrasting role of phospholipase C-gamma1 in the expression of immediate early genes induced by epidermal or platelet-derived growth factors

1 reference

12 December 2020

Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?

1 reference

12 December 2020

Linking animal models of psychosis to computational models of dopamine function.

1 reference

12 December 2020

Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern

1 reference

12 December 2020

Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor

1 reference

12 December 2020

Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines

1 reference

12 December 2020

Possible antipsychotic effects of minocycline in patients with schizophrenia

1 reference

12 December 2020

Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex

1 reference

12 December 2020

Localization of prostaglandin endoperoxide synthase in neurons and glia in monkey brain.

1 reference

12 December 2020

GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats

1 reference

12 December 2020

Sensorimotor gating and schizophrenia. Human and animal model studies

1 reference

12 December 2020

Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.

1 reference

12 December 2020

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

1 reference

12 December 2020

Nerve growth factor mediates phosphorylation of specific proteins

1 reference

12 December 2020

A new computer-assisted two-way avoidance conditioning equipment for rats: behavioral and pharmacological validation.

1 reference

12 December 2020

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

1 reference

12 December 2020

Epidermal growth factor and basic fibroblast growth factor have independent actions on mesencephalic dopamine neurons in culture.

1 reference

12 December 2020

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

1 reference

12 December 2020

Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry

1 reference

12 December 2020

A novel subtype of the prostacyclin receptor expressed in the central nervous system.

1 reference

12 December 2020

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

1 reference

12 December 2020

The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia

1 reference

12 December 2020

Tetrahydrobiopterin as a mediator of PC12 cell proliferation induced by EGF and NGF

1 reference

12 December 2020

Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain

1 reference

12 December 2020

The switching model of latent inhibition: an update of neural substrates

1 reference

12 December 2020

Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects

1 reference

12 December 2020

Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia

1 reference

12 December 2020

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

1 reference

12 December 2020

Prepulse inhibition of acoustic or trigeminal startle of rats by unilateral electrical stimulation of the inferior colliculus

1 reference

12 December 2020

10.1523/JNEUROSCI.2368-07.2007

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17881518%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

PubMed publication ID

17881518

1 reference